Angiotensin Converting Enzyme Insertion/Deletion Polymorphism in Korean Patients with Rheumatoid Vasculitis.
- Author:
Kyung Hae LEE
1
;
Jin Hyun WOO
;
Sook Kyoung KIM
;
Yong Wook PARK
;
Hye Soon LEE
;
Wan Sik UHM
;
Tae Hwan KIM
;
Jae Bum JUN
;
Sang Cheol BAE
;
Dae Hyun YOO
Author Information
1. Department of Internal Medicine, Hanyang University College of Medicine, Seoul, Korea. dhyoo@hanyang.ac.kr
- Publication Type:Original Article
- Keywords:
Rheumatoid arthritis;
Vasculitis;
Angiotensin converting enzyme gene insertion/ deletion polymorphism
- MeSH:
Angiotensins*;
Arthritis, Rheumatoid;
Cardiovascular Diseases;
DNA;
Exanthema;
Genotype;
Humans;
Peptidyl-Dipeptidase A*;
Polymerase Chain Reaction;
Polymorphism, Genetic;
Rheumatoid Vasculitis*;
Rheumatology;
Scleritis;
Vasculitis;
Vasoconstriction
- From:The Journal of the Korean Rheumatism Association
2004;11(4):358-364
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
OBJECTIVE: Rheumatoid arthritis has various extra-articular manifestations including rheumatoid vasculitis. Angiotensin converting enzyme (ACE) gene shows insertion/deletion polymorphism and has II, ID, DD genotypes. ACE gene is related with vasoconstriction and endothelial dysfunction in cardiovascular disease. This study was undertaken to determine the association between ACE gene polymorphism and rheumatoid vasculitis. METHODS: Twenty-nine patients were collected as rheumatoid vasculitis group. DNA was isolated from blood samples collected from 114 Korean rheumatoid arthritis patients meeting American College of rheumatology 1987 revised criteria, and 114 healthy control group. Genotyping for the angiotensin converting enzyme gene insertion/deletion polymorphism was performed by polymerase chain reaction method. RESULTS: As vasculitis manifestation, 15 patients showed neuropathy, 13 showed scleritis, 3 showed skin rash. In rheumatoid vasculitis group, II, ID and DD polymorphism was seen in 8 (27.6%), 15 (51.7%), 6 (20.7%) patients respectively and 39 (34.2%), 57 (50.0%), and 18 (15.8%) in normal controls. There was no skewing of ACE I/D polymorphism in compared with normal group. In rheumatoid arthritis control group, II, ID and DD polymorphism was seen in 37 (32.5%), 64 (56.1%), and 13 (11.4%) patients. Among rheumatoid arthritis patient, there was no significant difference between patient with vasculitis and without vasculitis. CONCLUSION: Our results showed that genetic polymorphisms of angiotensin converting enzyme insertion/deletion gene has no association with the susceptibility to rheumatoid vasculitis.
